News

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...
If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York, May 10, 2025 (GLOBE NEWSWIRE) - ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...
Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...
When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...